http://jnci.oxfordjournals.org/content/105/21/1667.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
         
      </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/105/21/1667" />
      <meta content="/jnci/105/21/1667.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis"
            name="DC.Title" />
      <meta content="10.1093/jnci/djt269" name="DC.Identifier" />
      <meta content="2013-11-06" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Xavier Paoletti" name="DC.Contributor" />
      <meta content="Koji Oba" name="DC.Contributor" />
      <meta content="Yung-Jue Bang" name="DC.Contributor" />
      <meta content="Harry Bleiberg" name="DC.Contributor" />
      <meta content="Narikazu Boku" name="DC.Contributor" />
      <meta content="Olivier Bouché" name="DC.Contributor" />
      <meta content="Paul Catalano" name="DC.Contributor" />
      <meta content="Nozomu Fuse" name="DC.Contributor" />
      <meta content="Stefan Michiels" name="DC.Contributor" />
      <meta content="Markus Moehler" name="DC.Contributor" />
      <meta content="Satoshi Morita" name="DC.Contributor" />
      <meta content="Yasuo Ohashi" name="DC.Contributor" />
      <meta content="Atsushi Ohtsu" name="DC.Contributor" />
      <meta content="Arnaud Roth" name="DC.Contributor" />
      <meta content="Philippe Rougier" name="DC.Contributor" />
      <meta content="Junichi Sakamoto" name="DC.Contributor" />
      <meta content="Daniel Sargent" name="DC.Contributor" />
      <meta content="Mitsuru Sasako" name="DC.Contributor" />
      <meta content="Kohei Shitara" name="DC.Contributor" />
      <meta content="Peter Thuss-Patience" name="DC.Contributor" />
      <meta content="Eric Van Cutsem" name="DC.Contributor" />
      <meta content="Tomasz Burzykowski" name="DC.Contributor" />
      <meta content="Marc Buyse" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Xavier Paoletti" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Koji Oba" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Yung-Jue Bang" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Harry Bleiberg" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Narikazu Boku" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Olivier Bouché" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Paul Catalano" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Nozomu Fuse" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Stefan Michiels" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Markus Moehler" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Satoshi Morita" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Yasuo Ohashi" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Atsushi Ohtsu" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Arnaud Roth" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Philippe Rougier" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Junichi Sakamoto" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Daniel Sargent" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Mitsuru Sasako" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Kohei Shitara" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Peter Thuss-Patience" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Eric Van Cutsem" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Tomasz Burzykowski" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta name="citation_author" content="Marc Buyse" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Biostatistics Department, INSEM U900 Institut Curie, Paris, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, Hokkaido, Japan (KO); Seoul National University College of Medicine, Oncology Division, Seoul, Korea (Y-JB); Jules Bordet Hospital, Brussels, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, Reims, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department of Biostatistics, Boston, MA (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, Kashiwa, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, Biostatistics and Epidemiology Department, Villejuif, France (SMi); Johannes Gutenberg University, Medical Department, Mainz, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, Kanagawa, Japan (SMo); University of Tokyo, Tokyo, Japan (YO); University Hospital, Department of Surgery, Geneva, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, Paris, France (PR); Tokai Central Hospital, Sohara, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, MN (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal Oncology, Aichi, Japan (KS); Charité-Universitätsmedizin Berlin, Department of Haematology, Oncology, and Tumorimmunology, Berlin, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, Leuven, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Diepenbeek, Belgium (TB, MB); International Drug Development Institute, Louvain-la-Neuve, Belgium (MB)." />
      <meta content="Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis"
            name="citation_title" />
      <meta content="11/06/2013" name="citation_date" />
      <meta content="105" name="citation_volume" />
      <meta content="21" name="citation_issue" />
      <meta content="1667" name="citation_firstpage" />
      <meta content="1670" name="citation_lastpage" />
      <meta content="105/21/1667" name="citation_id" />
      <meta content="105/21/1667" name="citation_id_from_sass_path" />
      <meta content="jnci;105/21/1667" name="citation_mjid" />
      <meta content="10.1093/jnci/djt269" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/105/21/1667.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/105/21/1667.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/105/21/1667.full.pdf"
            name="citation_pdf_url" />
      <meta content="/content/105/21.cover.gif" name="issue_cover_image" />
      <meta content="http://jnci.oxfordjournals.org/content/105/21/1667"
            name="citation_public_url" />
      <meta content="24108811" name="citation_pmid" />
      <meta name="citation_section" content="Brief Communication" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/105/21/1656.short" rel="prev" />
      <link href="/content/105/21/NP.1.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d28048966e1">var callbackToken='537BBB11AF8C1E6';</script><script type="text/javascript" id="session-d28048966e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:14:46.461-07:00';
            var gSessionId = '1CPaX0QAPHTmtw3b9RC8LA';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip ip';
            var gAuthnMethods2 = 'ip,ip';
            var gAuthnIPs = '18.189.59.169,18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/djt269");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("20131106");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F105%2F21%2F1667.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/105/21.toc">
                  <span xmlns="" class="volume-value">Volume 105</span>
                  <span xmlns="" class="issue-value"> Issue 21</span></a></li>
            <li>Pp. <span class="slug-pages">
                  1667-1670.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/105/21/1667.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view " itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Xavier+Paoletti&amp;sortspec=date&amp;submit=Submit">Xavier Paoletti</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="/search?author1=Koji+Oba&amp;sortspec=date&amp;submit=Submit">Koji Oba</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Yung-Jue+Bang&amp;sortspec=date&amp;submit=Submit">Yung-Jue Bang</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Harry+Bleiberg&amp;sortspec=date&amp;submit=Submit">Harry Bleiberg</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Narikazu+Boku&amp;sortspec=date&amp;submit=Submit">Narikazu Boku</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-6" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Olivier+Bouch%C3%A9&amp;sortspec=date&amp;submit=Submit">Olivier Bouché</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-7" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Paul+Catalano&amp;sortspec=date&amp;submit=Submit">Paul Catalano</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-8" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Nozomu+Fuse&amp;sortspec=date&amp;submit=Submit">Nozomu Fuse</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-9" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Stefan+Michiels&amp;sortspec=date&amp;submit=Submit">Stefan Michiels</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-10" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Markus+Moehler&amp;sortspec=date&amp;submit=Submit">Markus Moehler</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-11" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Satoshi+Morita&amp;sortspec=date&amp;submit=Submit">Satoshi Morita</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-12" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Yasuo+Ohashi&amp;sortspec=date&amp;submit=Submit">Yasuo Ohashi</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-13" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Atsushi+Ohtsu&amp;sortspec=date&amp;submit=Submit">Atsushi Ohtsu</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-14" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Arnaud+Roth&amp;sortspec=date&amp;submit=Submit">Arnaud Roth</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-15" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Philippe+Rougier&amp;sortspec=date&amp;submit=Submit">Philippe Rougier</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-16" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Junichi+Sakamoto&amp;sortspec=date&amp;submit=Submit">Junichi Sakamoto</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-17" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Daniel+Sargent&amp;sortspec=date&amp;submit=Submit">Daniel Sargent</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-18" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Mitsuru+Sasako&amp;sortspec=date&amp;submit=Submit">Mitsuru Sasako</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-19" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Kohei+Shitara&amp;sortspec=date&amp;submit=Submit">Kohei Shitara</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-20" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Peter+Thuss-Patience&amp;sortspec=date&amp;submit=Submit">Peter Thuss-Patience</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-21" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Eric+Van+Cutsem&amp;sortspec=date&amp;submit=Submit">Eric Van Cutsem</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-22" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Tomasz+Burzykowski&amp;sortspec=date&amp;submit=Submit">Tomasz Burzykowski</a></span> and 
                     </li>
                     <li class="last" id="contrib-23"><span class="name"><a class="name-search"
                              href="/search?author1=Marc+Buyse&amp;sortspec=date&amp;submit=Submit">Marc Buyse</a></span> 
                     </li>
                     <li class="on-behalf-of">the GASTRIC group</li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>
                           <strong>Affiliations of authors:</strong> Biostatistics Department, INSEM U900 Institut Curie, <span class="addr-line">Paris</span>, France (XP); Translational Research and Clinical Trial Center, Hokkaido University Hospital, <span class="addr-line">Hokkaido</span>, Japan (KO); Seoul National University College of Medicine, Oncology Division, <span class="addr-line">Seoul</span>, Korea (Y-JB); <span class="addr-line">Jules Bordet Hospital, Brussels</span>, Belgium (HB); St. Marianna University School of Medicine, Kawasaki, Japan (NB); Hôpital Robert Debré, <span class="addr-line">Reims</span>, Department of Clinical Oncology, France (OB); Dana-Farber Cancer Institute and Harvard School of Public Health, Department
                           of Biostatistics, <span class="addr-line">Boston, MA</span> (PC); National Cancer Center Hospital East, Department of Gastrointestinal Oncology, <span class="addr-line">Kashiwa</span>, Japan (NF, AO); Institut Gustave Roussy, Université Paris XI, <span class="addr-line">Biostatistics and Epidemiology Department, Villejuif</span>, France (SMi); Johannes Gutenberg University, Medical Department, <span class="addr-line">Mainz</span>, Germany (MM); Yokohama City University, Department of Biostatistics and Epidemiology, <span class="addr-line">Kanagawa</span>, Japan (SMo); University of Tokyo, <span class="addr-line">Tokyo</span>, Japan (YO); University Hospital, Department of Surgery, <span class="addr-line">Geneva</span>, Switzerland (AR); University Hospital Europeen Georges Pompidou, Gastro-enterology Department, <span class="addr-line">Paris</span>, France (PR); Tokai Central Hospital, <span class="addr-line">Sohara</span>, Japan (JS); Mayo Clinic, Division of Biomedical Statistics and Informatics, <span class="addr-line">Rochester, MN</span> (DS); National Cancer Center Hospital East, Kashiwa, Japan (MS); Aichi Cancer Center Hospital, Department of Gastrointestinal
                           Oncology, <span class="addr-line">Aichi</span>, Japan (KS); Charité-Universitätsmedizin Berlin, <span class="addr-line">Department of Haematology, Oncology, and Tumorimmunology, Berlin</span>, Germany (PT-P); University Hospital Gasthuisberg, Digestive Oncology Unit, <span class="addr-line">Leuven</span>, Belgium (EVC); Hasselt University, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, <span class="addr-line">Diepenbeek</span>, Belgium (TB, MB); International Drug Development Institute, <span class="addr-line">Louvain-la-Neuve</span>, Belgium (MB).
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1">
                        <strong>Correspondence to:</strong><br /> Xavier Paoletti, PhD, Bisotatistics Dept / INSERM U900, Institut Curie, 26 rue d’Ulm, 75005 Paris, France (e-mail: <span class="em-link"><span class="em-addr">xavier.paoletti{at}curie.net</span></span>).
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="2013-02-10"><span class="received-label">Received </span>February 10, 2013.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="2013-07-25"><span class="rev-recd-label">Revision received </span>July 25, 2013.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="2013-07-25"><span class="accepted-label">Accepted </span>July 25, 2013.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-1" title="Funding" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  
                  <p id="p-1">The traditional endpoint for assessing efficacy of chemotherapies for advanced/recurrent gastric cancer is overall survival
                     (OS), but OS requires prolonged follow-up. We investigated whether progression-free survival (PFS) is a valid surrogate for
                     OS. Using individual patient data from the GASTRIC meta-analysis, surrogacy of PFS was assessed through the correlation between
                     the endpoints and through the correlation between the treatment effects on the endpoints. External validation of the prediction
                     based on PFS was also evaluated. Individual data from 4069 patients in 20 randomized trials were analyzed. The rank correlation
                     coefficient between PFS and OS was 0.853 (95% confidence interval [CI] = 0.852 to 0.854). The <em>R</em>
                     <sup>2</sup> between treatment effects on PFS and on OS was 0.61 (95% CI = 0.04 to 1.00). Treatment effects on PFS and on OS were only
                     moderately correlated, and we could not confirm the validity of PFS as a surrogate endpoint for OS in advanced/recurrent gastric
                     cancer.
                  </p>
                  
               </div>
               <p id="p-2">The prognosis of patients with advanced or recurrent gastric cancer (AGC) remains poor, with a 1-year median overall survival
                  (OS) for commonly used chemotherapy regimens, consisting of fluoropyrimidine, platinum, taxane or anthracyclines agents (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>). The most important issue in the development of agents for AGC is their ability to prolong OS with acceptable toxicity.
                  Even though median postprogression survival ranges from 5 to 10 months, a validated shorter-term surrogate endpoint would
                  likely reduce drug development costs, sample sizes, or the duration of trials aimed at establishing the benefit of new drugs.
                  Progression-free survival (PFS) is commonly used in phase II and phase III trials. It has been evaluated as a surrogate endpoint
                  for OS in several types of cancers (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2–4</a>). The ability to predict clinical benefits on OS from earlier benefits on PFS could be useful at all stages of clinical development.
                  Here, we investigate the surrogacy of PFS for OS within the framework of the GASTRIC meta-analysis (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>).
               </p>
               <p id="p-3" class="indent">Trials were eligible if they were randomized, closed to accrual before the end of 2006, and collected individual patient data
                  on PFS. To explore the correlation between the treatment effects at the trial level, we relied on the comparison between the
                  experimental arms of the trials included in the meta-analysis with their corresponding control arms. We defined as experimental
                  the treatment that contained the larger number of drugs (eg, triple combinations vs double combinations). In case of equal
                  number of drugs, we defined as experimental the treatment that included the newer agent. When two experimental arms were tested
                  in the same trial, we combined their data for the purposes of the analyses. All data were centrally checked for inconsistencies
                  (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>).
               </p>
               <p id="p-4" class="indent">We used a meta-analytic validation approach (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>,<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>,<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). OS was defined as the time from randomization to death from any cause or to the last follow-up. PFS was the time to tumor
                  progression or death from any cause or time to the last follow-up assessment. A detailed description of statistical methods
                  used is provided in the <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djt269/-/DC1">Supplementary Material</a> (available online). For external validation, we applied the identified relation to predict the hazard ratio (HR) for OS (HR<sub>OS</sub>) from the hazard ratio for PFS (HR<sub>PFS</sub>) in randomized trials published since 2000 for which we had not obtained the individual patient data. We extracted the summary
                  statistics for both endpoints (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>) and compared the predicted value of HR<sub>OS</sub> to the one reported in the articles. To determine whether surrogacy also applied to other classes of agents, we extended
                  the validation to three published trials of targeted agents (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9–11</a>).
               </p>
               <p id="p-5" class="indent">Individual data were obtained on 4069 patients from 20 eligible randomized trials (<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12–30</a>). The characteristics of the trials have been described elsewhere (<a id="xref-ref-5-2" class="xref-bibr" href="#ref-5">5</a>). Thirteen trials defined the progression using radiological criteria, whereas seven used both clinical and radiological
                  assessments. Overall and at the trial level, the treatment effect on PFS (HR = 0.79; 95% confidence interval [CI] = 0.74 to
                  0.85) tended to be larger than on OS (HR = 0.85; 95% CI = 0.79 to 0.92) as shown on the forest plot of <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djt269/-/DC1">Supplementary Figures 1</a> and <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djt269/-/DC1">2</a> (available online).
               </p>
               <p id="p-6" class="indent">The individual-level association, as measured by the rank correlation coefficient, was 0.853 (95% CI = 0.852 to 0.854), indicating
                  substantial correlation between PFS and OS for a given patient. The association at the trial level between log HR<sub>OS</sub> and log HR<sub>PFS</sub> was only moderate, with a coefficient of determination, <em>R</em>
                  <sup>2</sup>, adjusted for the estimation errors (<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>), of 0.61 (95% CI = 0.04 to 1.00). The large confidence interval reflects the uncertainty around this estimate. The linear
                  regression model that relates the treatment effect on PFS and on OS adjusted for estimations errors was
               </p><span class="disp-formula" id="disp-formula-1"><img class="graphic" alt="Formula" src="1667/embed/graphic-1.gif" />
                  
                  </span><p id="p-7">where the standard errors of the intercept and the slope were 0.79 and 0.295, respectively. This is shown as a straight line
                  in <a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1</a>. The 95% prediction limits indicate the range of effect on OS that can be expected for a given effect on PFS. The moderate
                  predictive accuracy at the trial level is reflected by the large interval width and a surrogate threshold effect of 0.56;
                  hence, one should observe an HR<sub>PFS</sub> less than 0.56 to predict, with 95% probability, an HR<sub>OS</sub> less than 1.
               </p>
               <div id="F1" class="fig pos-float type-figure  odd">
                  <div class="fig-inline"><a href="1667/F1.expansion.html"><img alt="Figure 1." src="1667/F1.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                           <li><a href="1667/F1.expansion.html">In this window</a></li>
                           <li><a class="in-nw" href="1667/F1.expansion.html">In a new window</a></li>
                        </ul>
                        <ul class="fig-services">
                           <li class="ppt-link"><a href="/powerpoint/105/21/1667/F1">Download as PowerPoint Slide</a></li>
                        </ul>
                     </div>
                  </div>
                  <div class="fig-caption"><span class="fig-label">Figure 1.</span> 
                     
                     <p id="p-8" class="first-child">Trial-level association between treatment effects. Log scale was used for the x and y axes; the <strong>horizontal line</strong> (<strong>circles</strong>) corresponds to the hazard ratio (HR) on overall survival of 1, which indicates the absence of effect on the overall survival.
                        At the crossing point, the vertical line corresponds to the minimum amount of effect on PFS that will predict a hazard ratio
                        on OS below 1 with 95% probability. This indicates the surrogate threshold effect.
                     </p>
                     
                     <div class="sb-div caption-clear"></div>
                  </div>
               </div>
               <p id="p-9" class="indent">Validation on independent literature data (<a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9–11</a>,<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32–39</a>) is shown in <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a> and <a href="http://jnci.oxfordjournals.org/lookup/suppl/doi:10.1093/jnci/djt269/-/DC1">Supplementary Figure 3</a> (available online). The larger the number of progressions, the more precise the prediction; however, precision is limited
                  by the variability of the regression line. The observed HR<sub>OS</sub> fell within the prediction interval in all trials, even in trials using humanized monoclonal antibodies [Trastuzumab (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>), bevaxizumab (<a id="xref-ref-9-3" class="xref-bibr" href="#ref-9">9</a>), matuzumab (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>)]. However, in the trial that concluded a statistically significant benefit of trastuzumab on OS (<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>), the effect on PFS was smaller than the surrogate threshold effect and therefore could not have been used to predict a statistically
                  significant effect on OS.
               </p>
               <div class="table pos-float" id="T1">
                  <div class="table-inline">
                     <div class="callout"><span>View this table:</span><ul class="callout-links">
                           <li><a href="1667/T1.expansion.html">In this window</a></li>
                           <li><a class="in-nw" href="1667/T1.expansion.html">In a new window</a></li>
                        </ul>
                     </div>
                  </div>
                  <div class="table-caption"><span class="table-label">Table 1.</span> 
                     
                     <p id="p-10" class="first-child">Observed and predicted treatment effect on overall survival, based on the observed treatment effect on progression-free survival*</p>
                     
                     <div class="sb-div caption-clear"></div>
                  </div>
               </div>
               <p id="p-13" class="indent">This is the first study based on individual patient data to evaluate whether PFS is a reasonable surrogate endpoint to use
                  for randomized trials in AGC. Our results show a high correlation of PFS and OS in individual patients but only a modest correlation
                  (<em>R</em>
                  <sup>2</sup> = 0.61) between treatment effects on PFS and OS. It is lower than that found in trials of 5-fluorouracil–based therapies
                  for advanced colorectal cancer (<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>). The correlation was also lower than in the adjuvant setting (<a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a>).
               </p>
               <p id="p-14" class="indent">Possible limitations that may explain the moderate correlation observed in our analysis include the numerous processes involved
                  in the progression of stomach cancer (eg, local or distant metastasis, peritoneum involvement), the use of clinical and radiological
                  assessments for progression, and the impact of our definition of investigational treatment related to the heterogeneity in
                  chemotherapies considered here; variability in the investigated treatments and in the effects of the treatments is a condition
                  to generalize any results to future trials. Last, patients included in more recent trials received second-line treatments,
                  including crossover (<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>), which may have diluted the effect of first-line treatment on OS (<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>). Because not all trials reported the same information at baseline, we could not assess the surrogacy in clinically relevant
                  subset analyses.
               </p>
               <p id="p-15" class="indent">All in all, we would not conclude that PFS is an adequate surrogate for OS in AGC. No precise prediction of the effect of
                  a treatment on OS can be reliably drawn from the effect estimated on PFS.
               </p>
               <div class="section" id="sec-1">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#notes-1" title="Notes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Funding</h2>
                  
                  <p id="p-16">This work was partially supported by the <span class="funding-source">French Institut National du Cancer</span> (grant <span class="award-id" id="award-id-1">PHRC GASTRIC</span>); the <span class="funding-source">Clinical Research Support Unit</span>; and the <span class="funding-source">Epidemiological and Clinical Research Information Network</span>. A meeting was supported financially by unrestricted grants from <span class="funding-source">GlaxoSmithKline</span>. The funders were not present at the meeting, were not involved in the analyses of the data, and did not comment on the present
                     paper.
                  </p>
                  
               </div>
               <div class="section notes" id="notes-1">
                  <div class="section-nav"><a href="#sec-1" title="Funding" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Notes</h2>
                  
                  <p id="p-17">X. Paoletti and K. Oba as well as T. Burzykovski and M. Buyse contributed equally to this work T. Burzykowski and M. Buyse
                     contributed equally to this work. A first draft of this manuscript was developed at a meeting of investigators in Sapporo,
                     Japan, September 24–28, 2010. The meeting was supported financially by unrestricted grants from GlaxoSmithKline.
                  </p>
                  
                  <p id="p-18">The GASTRIC Investigators: Secretariat: Marc Buyse, Stefan Michiels, Kenichi Nakamura, Koji Oba, Xavier Paoletti, Philippe
                     Rougier, and Seiichiro Yamamoto. Steering Committee: Yung-Jue Bang (Seoul National University College of Medicine, Seoul,
                     Korea); Harry Bleiberg (Jules Bordet Hospital, Brussels, Belgium); Tomasz Burzykowski (Hasselt University, Diepenbeek, Belgium);
                     Marc Buyse (International Drug Development Institute, Louvain-la-Neuve, Belgium);Catherine Delbaldo (Hôpital Louis Mourier,
                     Colombes, France); Stefan Michiels (Institut Gustave Roussy, Université Paris XI, Villejuif, France); Satoshi Morita (Yokohama
                     City University, Kanagawa, Japan); Koji Oba (Hokkaido University Hospital, Hokkaido, Japan); Yasuo Ohashi (University of Tokyo,
                     Tokyo, Japan); Xavier Paoletti (Institut Curie, Paris, France); Jean-Pierre Pignon (Institut Gustave-Roussy, Villejuif, France);
                     Philippe Rougier (University Hospital Europeen Georges Pompidou, Paris, France); Junichi Sakamoto (Tokai Central Hospital,
                     Sohara, Japan); Daniel Sargent (Mayo Clinic, Rochester, MN); Mitsuru Sasako (Hyogo College of Medicine, Hyogo, Japan); and
                     Eric Van Cutsem (Digestive Oncology Unit, University Hospital Gasthuisberf, Leuven, Belgium).Collaborators: J. Ajani, N. Boku,
                     O. Bouche, J. Buckner, C. Coombes, S. Cullinan, M. Dank, N. Fuse, B. Glimelius, R. Hawkins, W. Koizumi, M. Moehler, Y. Nio,
                     A. Ohtsu, A. Roth, K. Shitara, P. Thuss-Patience, A. Tsuburaya, E. Van Cutsem, U. Vanhoefer, J. Wils, and Y. Yamamura. <em>Writing committee:</em> Xavier Paoletti, Koji Oba, Tomasz Burzykowski, Yung-Jue Bang, Harry Bleiberg, Narikazu Boku, Olivier Bouché, Paul Catalano,
                     Nozomu Fuse, Stefan Michiels, Markus Moehler, Satoshi Morita, Yasuo Ohashi, Atsushi Ohtsu, Arnaud Roth, Philippe Rougier,
                     Junichi Sakamoto, Daniel Sargent, Mitsuru Sasako, Kohei Shitara, Peter Thuss-Patience, Eric van Cutsem, and Marc Buyse.
                  </p>
                  
                  <p id="p-19">This project was initiated under the auspice of the French Institut National du Cancer, who served as a sponsor. The French
                     Institut National du Cancer did not participate in the design of the study. It participated in the conduct of the study at
                     an earlier stage by centralizing all the databases and by providing administrative and data management support. The sponsor
                     had no role in the preparation, review, or approval of the manuscript.
                  </p>
                  
                  <p id="p-20">The GASTRIC Group thanks all patients who took part in the trials and contributed to this research. The meta-analysis would
                     not have been possible without their participation or without active participation of the collaborating institutions that
                     provided their trial data (East Central Oncology Group; European Organization of Research and Treatment of Cancer; Fédération
                     Francophone de Cancérologie Digestive; Italian Trials in Medical Oncology; Japanese Cooperative Oncology Group; North Central
                     Cancer Treatment Group; South West Oncology Group; the V325 Study Group; the Swiss Group for Clinical Cancer Research; the
                     Kyoto Research Group for Chemotherapy of Gastric Cancer, the Medizinische Klinik mit Schwerpunkt Haëmatologie und Onkologie,
                     Charité, Universitatsmedizin Berlin; the Center for Caring Sciences, University of Uppsala Sweden. We thank Nicolas Thammavong
                     for the data management.
                  </p>
                  
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">© The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#notes-1" title="Notes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.1"
                             data-doi="10.1016/j.ejca.2012.12.016">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Oba</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Paoletti</span>  <span class="cit-name-given-names">X</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bang</span>  <span class="cit-name-given-names">YJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis</span>.
                                 <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr>.
                                 <span class="cit-pub-date">2013</span>;<span class="cit-vol">49</span>(<span class="cit-issue">7</span>):<span class="cit-fpage">1565</span>–<span class="cit-lpage">1577</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ejca.2012.12.016&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=23352439&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000317563600007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Role%20of%20chemotherapy%20for%20advanced%2Frecurrent%20gastric%20cancer%3A%20an%20individual-patient-data%20meta-analysis&amp;author=K%20Oba&amp;author=X%20Paoletti&amp;author=YJ%20Bang&amp;publication_year=2013&amp;journal=Eur%20J%20Cancer&amp;volume=49&amp;issue=7&amp;pages=1565-1577">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.2"
                             data-doi="10.1093/jnci/djp369">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Broglio</span>  <span class="cit-name-given-names">KR</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Berry</span>  <span class="cit-name-given-names">DA</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Detecting an overall survival benefit that is derived from progression-free survival</span>.
                                 <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">101</span>(<span class="cit-issue">23</span>):<span class="cit-fpage">1642</span>–<span class="cit-lpage">1649</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=101/23/1642"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text"
                           id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.3"
                             data-doi="10.1200/JCO.2007.10.8407">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burzykowski</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buyse</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Piccart-Gebhart</span>  <span class="cit-name-given-names">MJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end
                                    points in metastatic breast cancer</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">26</span>(<span class="cit-issue">12</span>):<span class="cit-fpage">1987</span>–<span class="cit-lpage">1992</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=26/12/1987"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text"
                           id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.4"
                             data-doi="10.1200/JCO.2007.11.8836">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buyse</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burzykowski</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Carroll</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Progression-free survival is a surrogate for survival in advanced colorectal cancer</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2007</span>;<span class="cit-vol">25</span>(<span class="cit-issue">33</span>):<span class="cit-fpage">5218</span>–<span class="cit-lpage">5224</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=25/33/5218"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text"
                           id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.5"
                             data-doi="10.1016/j.ejca.2012.12.016">
                           <div class="cit-metadata"><cite><span class="cit-auth cit-collab">GASTRIC</span>.
                                 <span class="cit-article-title">Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis</span>.
                                 <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr>.
                                 <span class="cit-pub-date">2013</span>; <span class="cit-vol">49</span>(<span class="cit-issue">7</span>):<span class="cit-fpage">1565</span>–<span class="cit-lpage">1577</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ejca.2012.12.016&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=23352439&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000317563600007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.6"
                             data-doi="10.1002/sim.4780141902">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stewart</span>  <span class="cit-name-given-names">LA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Clarke</span>  <span class="cit-name-given-names">MJ</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group</span>.
                                 <abbr class="cit-jnl-abbrev">Stat Med</abbr>.
                                 <span class="cit-pub-date">1995</span>;<span class="cit-vol">14</span>(<span class="cit-issue">19</span>):<span class="cit-fpage">2057</span>–<span class="cit-lpage">2079</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/sim.4780141902&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8552887&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1995RX95900001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Practical%20methodology%20of%20meta-analyses%20%28overviews%29%20using%20updated%20individual%20patient%20data.%20Cochrane%20Working%20Group&amp;author=LA%20Stewart&amp;author=MJ%20Clarke&amp;publication_year=1995&amp;journal=Stat%20Med&amp;volume=14&amp;issue=19&amp;pages=2057-2079">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text"
                           id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.7"
                             data-doi="10.1111/1467-9876.00244">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burzykowski</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Molenberghs</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buyse</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Geys</span>  <span class="cit-name-given-names">H</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Validation of surrogate endpoints in multiple randomized clinical trials with failure time endpoints</span>.
                                 <abbr class="cit-jnl-abbrev">J R Stat Soc Series C Appl Stat</abbr>.
                                 <span class="cit-pub-date">2001</span>; <span class="cit-vol">50</span>(<span class="cit-issue">4</span>): <span class="cit-fpage">405</span>–<span class="cit-lpage">422</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/1467-9876.00244&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Validation%20of%20surrogate%20endpoints%20in%20multiple%20randomized%20clinical%20trials%20with%20failure%20time%20endpoints&amp;author=T%20Burzykowski&amp;author=G%20Molenberghs&amp;author=M%20Buyse&amp;author=H%20Geys&amp;publication_year=2001&amp;journal=J%20R%20Stat%20Soc%20Series%20C%20Appl%20Stat&amp;volume=50&amp;issue=4&amp;pages=405-422">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text"
                           id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.8"
                             data-doi="10.1002/(SICI)1097-0258(19981230)17:24&lt;2815::AID-SIM110&gt;3.0.CO;2-8">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Parmar</span>  <span class="cit-name-given-names">MK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Torri</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stewart</span>  <span class="cit-name-given-names">L</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints</span>.
                                 <abbr class="cit-jnl-abbrev">Stat Med</abbr>.
                                 <span class="cit-pub-date">1998</span>;<span class="cit-vol">17</span>(<span class="cit-issue">24</span>):<span class="cit-fpage">2815</span>–<span class="cit-lpage">2834</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/(SICI)1097-0258(19981230)17:24%3C2815::AID-SIM110%3E3.0.CO;2-8&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9921604&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000077527600003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Extracting%20summary%20statistics%20to%20perform%20meta-analyses%20of%20the%20published%20literature%20for%20survival%20endpoints&amp;author=MK%20Parmar&amp;author=V%20Torri&amp;author=L%20Stewart&amp;publication_year=1998&amp;journal=Stat%20Med&amp;volume=17&amp;issue=24&amp;pages=2815-2834">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text"
                           id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.9"
                             data-doi="10.1200/JCO.2011.36.2236">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ohtsu</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shah</span>  <span class="cit-name-given-names">MA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Van Cutsem</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind,
                                    placebo-controlled phase III study</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.; <span class="cit-pub-date">2011</span>; <span class="cit-vol">29</span>(<span class="cit-issue">30</span>):<span class="cit-fpage">3968</span>–<span class="cit-lpage">3976.</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=29/30/3968"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.10"
                             data-doi="10.1016/S0140-6736(10)61121-X">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bang</span>  <span class="cit-name-given-names">YJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Van Cutsem</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Feyereislova</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or
                                    gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial</span>.
                                 <abbr class="cit-jnl-abbrev">Lancet</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">376</span>(<span class="cit-issue">9742</span>):<span class="cit-fpage">687</span>–<span class="cit-lpage">697</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(10)61121-X&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20728210&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000281582900028&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Trastuzumab%20in%20combination%20with%20chemotherapy%20versus%20chemotherapy%20alone%20for%20treatment%20of%20HER2-positive%20advanced%20gastric%20or%20gastro-oesophageal%20junction%20cancer%20%28ToGA%29%3A%20a%20phase%203%2C%20open-label%2C%20randomised%20controlled%20trial&amp;author=YJ%20Bang&amp;author=E%20Van%20Cutsem&amp;author=A%20Feyereislova&amp;publication_year=2010&amp;journal=Lancet&amp;volume=376&amp;issue=9742&amp;pages=687-697">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text"
                           id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.11"
                             data-doi="10.1093/annonc/mdq247">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rao</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Starling</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cunningham</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as
                                    first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>.; <span class="cit-pub-date">2010</span>; <span class="cit-vol">21</span>(<span class="cit-issue">11</span>):<span class="cit-fpage">2213</span>–<span class="cit-lpage">2219</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=21/11/2213"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text"
                           id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.12">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Douglass</span>  <span class="cit-name-given-names">HO</span>  <span class="cit-name-suffix">Jr</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lavin</span>  <span class="cit-name-given-names">PT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Goudsmit</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Klaassen</span>  <span class="cit-name-given-names">DJ</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Paul</span>  <span class="cit-name-given-names">AR</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, adriamycin, and 5-fluorouracil
                                    in advanced measurable gastric cancer (EST 2277)</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">1984</span>;<span class="cit-vol">2</span>(<span class="cit-issue">12</span>):<span class="cit-fpage">1372</span>–<span class="cit-lpage">1381</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=6439836&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1984TX00100010&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=An%20Eastern%20Cooperative%20Oncology%20Group%20evaluation%20of%20combinations%20of%20methyl-CCNU%2C%20mitomycin%20C%2C%20adriamycin%2C%20and%205-fluorouracil%20in%20advanced%20measurable%20gastric%20cancer%20%28EST%202277%29&amp;author=HO%20Douglass&amp;author=PT%20Lavin&amp;author=A%20Goudsmit&amp;author=DJ%20Klaassen&amp;author=AR%20Paul&amp;publication_year=1984&amp;journal=J%20Clin%20Oncol&amp;volume=2&amp;issue=12&amp;pages=1372-1381">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">13.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.13"
                             data-doi="10.1001/jama.1985.03350380077025">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cullinan</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moertel</span>  <span class="cit-name-given-names">CG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fleming</span>  <span class="cit-name-given-names">TR</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil
                                    vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin</span>.
                                 <abbr class="cit-jnl-abbrev">JAMA</abbr>.
                                 <span class="cit-pub-date">1985</span>;<span class="cit-vol">253</span>(<span class="cit-issue">14</span>):<span class="cit-fpage">2061</span>–<span class="cit-lpage">2067</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1001/jama.1985.03350380077025&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=2579257&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1985AFC0600022&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20comparison%20of%20three%20chemotherapeutic%20regimens%20in%20the%20treatment%20of%20advanced%20pancreatic%20and%20gastric%20carcinoma.%20Fluorouracil%20vs%20fluorouracil%20and%20doxorubicin%20vs%20fluorouracil%2C%20doxorubicin%2C%20and%20mitomycin&amp;author=SA%20Cullinan&amp;author=CG%20Moertel&amp;author=TR%20Fleming&amp;publication_year=1985&amp;journal=JAMA&amp;volume=253&amp;issue=14&amp;pages=2061-2067">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">14.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.14">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wils</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Klein</span>  <span class="cit-name-given-names">HO</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wagener</span>  <span class="cit-name-given-names">DJ</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Sequential high-dose methotrexate and fluorouracil combined with doxorubicin—a step ahead in the treatment of advanced gastric
                                    cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">1991</span>;<span class="cit-vol">9</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">827</span>–<span class="cit-lpage">831</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=9/5/827"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">15.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.15">
                           <div class="cit-metadata"><cite><span class="cit-auth cit-collab">Kyoto Research Group for Chemotherapy of Gastric Aancer</span>.
                                 <span class="cit-article-title">A randomized, comparative study of combination chemotherapies in advanced gastric cancer: 5-fluorouracil and cisplatin (FP)
                                    versus 5-fluorouracil, cisplatin, and 4’-epirubicin (FPEPIR)</span>.
                                 <abbr class="cit-jnl-abbrev">Anticancer Res</abbr>.
                                 <span class="cit-pub-date">1992</span>;<span class="cit-vol">12</span>(<span class="cit-issue">6B</span>):<span class="cit-fpage">1983</span>–<span class="cit-lpage">1988</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1295444&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1992KP43000009&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">16.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.16">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cullinan</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moertel</span>  <span class="cit-name-given-names">CG</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wieand</span>  <span class="cit-name-given-names">HS</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer.
                                    North Central Cancer Treatment Group</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">1994</span>;<span class="cit-vol">12</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">412</span>–<span class="cit-lpage">416</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=12/2/412"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">17.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.17"
                             data-doi="10.1023/A:1008243606668">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Glimelius</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ekstrom</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hoffman</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>.
                                 <span class="cit-pub-date">1997</span>;<span class="cit-vol">8</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">163</span>–<span class="cit-lpage">168</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=8/2/163"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">18.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.18">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Vanhoefer</span>  <span class="cit-name-given-names">U</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rougier</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wilke</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide,
                                    leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European
                                    Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2000</span>;<span class="cit-vol">18</span>(<span class="cit-issue">14</span>):<span class="cit-fpage">2648</span>–<span class="cit-lpage">2657</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=18/14/2648"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">19.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.19">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kim</span>  <span class="cit-name-given-names">TW</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">A prospective randomized phase III trial of 5-fluorouracil and cusplatin (FP) versus epirubicin, cisplatin, and 5-FU (ECF)
                                    in the treatment of patients with previously untreated advanced gastric cancer (AGC)</span>.
                                 <abbr class="cit-jnl-abbrev">Eur J Cancer</abbr>.
                                 <span class="cit-pub-date">2001</span>; <span class="cit-vol">47</span>(<span class="cit-issue">3</span>)<span class="cit-fpage">S314</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20prospective%20randomized%20phase%20III%20trial%20of%205-fluorouracil%20and%20cusplatin%20%28FP%29%20versus%20epirubicin%2C%20cisplatin%2C%20and%205-FU%20%28ECF%29%20in%20the%20treatment%20of%20patients%20with%20previously%20untreated%20advanced%20gastric%20cancer%20%28AGC%29&amp;author=TW%20Kim&amp;publication_year=2001&amp;journal=Eur%20J%20Cancer&amp;volume=47&amp;issue=3&amp;pages=S314">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">20.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.20"
                             data-doi="10.1200/JCO.2003.04.130">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ohtsu</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shimada</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shirao</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin
                                    in patients with unresectable, advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG9205)</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2003</span>;<span class="cit-vol">21</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">54</span>–<span class="cit-lpage">59</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=21/1/54"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">21.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.21">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koizumi</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fukuyama</span>  <span class="cit-name-given-names">Y</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fukuda</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced
                                    unresectable gastric cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Anticancer Res</abbr>.
                                 <span class="cit-pub-date">2004</span>;<span class="cit-vol">24</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">2465</span>–<span class="cit-lpage">2470</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=anticanres&amp;resid=24/4/2465"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">22.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.22"
                             data-doi="10.1093/annonc/mdh473">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pozzo</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Barone</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Szanto</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric
                                    junction adenocarcinoma: results of a randomized phase II study</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>.
                                 <span class="cit-pub-date">2004</span>;<span class="cit-vol">15</span>(<span class="cit-issue">12</span>):<span class="cit-fpage">1773</span>–<span class="cit-lpage">1781</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=15/12/1773"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">23.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.23"
                             data-doi="10.1093/annonc/mdi270">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bouche</span>  <span class="cit-name-given-names">O</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ychou</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burtin</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of
                                    the FFCD randomized phase III trial (8801)</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>.
                                 <span class="cit-pub-date">2005</span>;<span class="cit-vol">16</span>(<span class="cit-issue">9</span>):<span class="cit-fpage">1488</span>–<span class="cit-lpage">1497</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=16/9/1488"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">24.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.24"
                             data-doi="10.1200/JCO.2005.17.376">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ajani</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fodor</span>  <span class="cit-name-given-names">MB</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tjulandin</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated,
                                    advanced gastric, or gastroesophageal adenocarcinoma</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2005</span>;<span class="cit-vol">23</span>(<span class="cit-issue">24</span>):<span class="cit-fpage">5660</span>–<span class="cit-lpage">5667</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=23/24/5660"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">25.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.25"
                             data-doi="10.1038/sj.bjc.6602649">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moehler</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Eimermacher</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Siebler</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin,
                                    and etoposide (ELF) in untreated metastatic gastric cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Br J Cancer</abbr>.
                                 <span class="cit-pub-date">2005</span>;<span class="cit-vol">92</span>(<span class="cit-issue">12</span>):<span class="cit-fpage">2122</span>–<span class="cit-lpage">2128</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1038/sj.bjc.6602649&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15942629&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000229794400005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Randomised%20phase%20II%20evaluation%20of%20irinotecan%20plus%20high-dose%205-fluorouracil%20and%20leucovorin%20%28ILF%29%20vs%205-fluorouracil%2C%20leucovorin%2C%20and%20etoposide%20%28ELF%29%20in%20untreated%20metastatic%20gastric%20cancer&amp;author=M%20Moehler&amp;author=A%20Eimermacher&amp;author=J%20Siebler&amp;publication_year=2005&amp;journal=Br%20J%20Cancer&amp;volume=92&amp;issue=12&amp;pages=2122-2128">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">26.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.26"
                             data-doi="10.1200/JCO.2005.02.163">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Thuss-Patience</span>  <span class="cit-name-given-names">PC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kretzschmar</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Repp</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma:
                                    a randomized phase II study</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2005</span>;<span class="cit-vol">23</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">494</span>–<span class="cit-lpage">501</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=23/3/494"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">27.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.27"
                             data-doi="10.1200/JCO.2006.06.8429">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Van Cutsem</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moiseyenko</span>  <span class="cit-name-given-names">VM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tjulandin</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy
                                    for advanced gastric cancer: a report of the V325 Study Group</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2006</span>;<span class="cit-vol">24</span>(<span class="cit-issue">31</span>):<span class="cit-fpage">4991</span>–<span class="cit-lpage">4997</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=24/31/4991"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">28.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.28"
                             data-doi="10.1200/JCO.2006.08.0135">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roth</span>  <span class="cit-name-given-names">AD</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fazio</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Stupp</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment
                                    for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2007</span>;<span class="cit-vol">25</span>(<span class="cit-issue">22</span>):<span class="cit-fpage">3217</span>–<span class="cit-lpage">3223</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=25/22/3217"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">29.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.29"
                             data-doi="10.1093/annonc/mdn166">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Dank</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Zaluski</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Barone</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil
                                    in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">19</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">1450</span>–<span class="cit-lpage">1457</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=19/8/1450"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text"
                           id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.30"
                             data-doi="10.1016/S1470-2045(09)70259-1">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boku</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yamamoto</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Fukuda</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3
                                    study</span>.
                                 <abbr class="cit-jnl-abbrev">Lancet Oncol</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">10</span>(<span class="cit-issue">11</span>):<span class="cit-fpage">1063</span>–<span class="cit-lpage">1069</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S1470-2045(09)70259-1&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19818685&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000271852800015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Fluorouracil%20versus%20combination%20of%20irinotecan%20plus%20cisplatin%20versus%20S-1%20in%20metastatic%20gastric%20cancer%3A%20a%20randomised%20phase%203%20study&amp;author=N%20Boku&amp;author=S%20Yamamoto&amp;author=H%20Fukuda&amp;publication_year=2009&amp;journal=Lancet%20Oncol&amp;volume=10&amp;issue=11&amp;pages=1063-1069">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">31.</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31. in text"
                           id="ref-31">↵</a>
                        
                        
                        <div class="cit ref-cit ref-book" id="cit-105.21.1667.31">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burzykowski</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Molenberghs</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Buyse</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>.
                                 <span class="cit-source">The Evaluation of Surrogate Endpoints</span>.
                                 <span class="cit-publ-loc">New York</span>: <span class="cit-publ-name">Springer</span>; <span class="cit-pub-date">2006</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20Evaluation%20of%20Surrogate%20Endpoints&amp;author=T%20Burzykowski&amp;author=G%20Molenberghs&amp;author=M%20Buyse&amp;publication_year=2006">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">32.</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32. in text"
                           id="ref-32">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.32"
                             data-doi="10.1200/JCO.2009.25.4706">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ajani</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rodriguez</span>  <span class="cit-name-given-names">W</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bodoky</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal
                                    adenocarcinoma study: the FLAGS trial</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2010</span>;<span class="cit-vol">28</span>(<span class="cit-issue">9</span>):<span class="cit-fpage">1547</span>–<span class="cit-lpage">1553</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=28/9/1547"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">33.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.33"
                             data-doi="10.1200/JCO.2007.13.9378">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Al-Batran</span>  <span class="cit-name-given-names">SE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hartmann</span>  <span class="cit-name-given-names">JT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Probst</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin:
                                    a study of the Arbeitsgemeinschaft Internistische Onkologie</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">26</span>(<span class="cit-issue">9</span>):<span class="cit-fpage">1435</span>–<span class="cit-lpage">1442</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=26/9/1435"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">34.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.34"
                             data-doi="10.1056/NEJMoa073149">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cunningham</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Starling</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rao</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Capecitabine and oxaliplatin for advanced esophagogastric cancer</span>.
                                 <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">358</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">36</span>–<span class="cit-lpage">46</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa073149&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=18172173&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000252031200006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Capecitabine%20and%20oxaliplatin%20for%20advanced%20esophagogastric%20cancer&amp;author=D%20Cunningham&amp;author=N%20Starling&amp;author=S%20Rao&amp;publication_year=2008&amp;journal=N%20Engl%20J%20Med&amp;volume=358&amp;issue=1&amp;pages=36-46">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">35.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.35"
                             data-doi="10.1093/annonc/mdn717">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kang</span>  <span class="cit-name-given-names">YK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kang</span>  <span class="cit-name-given-names">WK</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Shin</span>  <span class="cit-name-given-names">DB</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised
                                    phase III noninferiority trial</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">20</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">666</span>–<span class="cit-lpage">673</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=20/4/666"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">36.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.36"
                             data-doi="10.1002/cncr.25729">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Jeung</span>  <span class="cit-name-given-names">HC</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Rha</span>  <span class="cit-name-given-names">SY</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Im</span>  <span class="cit-name-given-names">CK</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation
                                    of SPARC expression for personalized therapy</span>.
                                 <abbr class="cit-jnl-abbrev">Cancer</abbr>.
                                 <span class="cit-pub-date">2011</span>;<span class="cit-vol">117</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">2050</span>–<span class="cit-lpage">2057</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/cncr.25729&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21523716&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000290161100005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20randomized%20phase%202%20study%20of%20docetaxel%20and%20S-1%20versus%20docetaxel%20and%20cisplatin%20in%20advanced%20gastric%20cancer%20with%20an%20evaluation%20of%20SPARC%20expression%20for%20personalized%20therapy&amp;author=HC%20Jeung&amp;author=SY%20Rha&amp;author=CK%20Im&amp;publication_year=2011&amp;journal=Cancer&amp;volume=117&amp;issue=10&amp;pages=2050-2057">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">37.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.37">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Moehler</span>  <span class="cit-name-given-names">MH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Siebler</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Hoehler</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Janssen</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wein</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Menges</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">CPT11/FA/5-FU versus ELF in chemonaive patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal
                                    junction: a randomized phase II study</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2004</span>; <span class="cit-vol">22</span>(<span class="cit-issue">14S</span>): <span class="cit-fpage">4064</span>.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=CPT11%2FFA%2F5-FU%20versus%20ELF%20in%20chemonaive%20patients%20with%20advanced%20or%20metastatic%20adenocarcinoma%20of%20the%20stomach%20or%20gastroesophageal%20junction%3A%20a%20randomized%20phase%20II%20study&amp;author=MH%20Moehler&amp;author=J%20Siebler&amp;author=T%20Hoehler&amp;author=J%20Janssen&amp;author=A%20Wein&amp;author=M%20Menges&amp;publication_year=2004&amp;journal=J%20Clin%20Oncol&amp;volume=22&amp;issue=14S&amp;pages=4064">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">38.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.38"
                             data-doi="10.1093/annonc/mdm502">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Park</span>  <span class="cit-name-given-names">SH</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nam</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Park</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination
                                    chemotherapy for advanced gastric cancer</span>.
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>.
                                 <span class="cit-pub-date">2008</span>;<span class="cit-vol">19</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">729</span>–<span class="cit-lpage">733</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=19/4/729"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">39.</span>
                        
                        
                        <div class="cit ref-cit ref-journal no-rev-xref" id="cit-105.21.1667.39"
                             data-doi="10.1200/JCO.2002.08.105">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ross</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nicolson</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cunningham</span>  <span class="cit-name-given-names">D</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin,
                                    cisplatin, and PVI 5-FU in advanced esophagogastric cancer</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2002</span>;<span class="cit-vol">20</span>(<span class="cit-issue">8</span>):<span class="cit-fpage">1996</span>–<span class="cit-lpage">2004</span>.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=20/8/1996"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">40.</span><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference 40. in text"
                           id="ref-40">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-105.21.1667.40">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Burzykowski</span>  <span class="cit-name-given-names">T</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Bang</span>  <span class="cit-name-given-names">Y</span></span></li>
                              </ol><cite>.
                                 <span class="cit-article-title">Disease-free survival as a surrogate endpoint for overall survival in an adjuvant trial of curatively resected stomach cancer
                                    using individual patient data meta-analysis</span>.
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>.
                                 <span class="cit-pub-date">2009</span>;<span class="cit-vol">27</span>(<span class="cit-issue">15s</span>):abstract 4517.</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Disease-free%20survival%20as%20a%20surrogate%20endpoint%20for%20overall%20survival%20in%20an%20adjuvant%20trial%20of%20curatively%20resected%20stomach%20cancer%20using%20individual%20patient%20data%20meta-analysis&amp;author=T%20Burzykowski&amp;author=Y%20Bang&amp;publication_year=2009&amp;journal=J%20Clin%20Oncol&amp;volume=27&amp;issue=15s">Google Scholar</a></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div id="related">
               <h2>Related articles</h2>
               <ul class="related-list">
                  <div class="cit has-earlier-version">
                     <div class="cit-metadata"><span class="cit-first-element cit-section">Solicited Editorial<span class="cit-sep cit-sep-after-article-section">:</span> </span><ul class="cit-auth-list">
                           <li class="first-item"><span class="cit-auth cit-auth-type-author">Colin B. Begg</span></li>  
                        </ul><span class="cit-title">Justifying the Choice of Endpoints for Clinical Trials </span> <cite><abbr title="Journal of the National Cancer Institute" class="site-title">JNCI J Natl Cancer Inst</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2013<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">105 </span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>21<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-pages"><span class="cit-first-page">1594</span><span class="cit-sep">-</span><span class="cit-last-page">1595</span> </span><span class="cit-doi"><span class="cit-sep cit-sep-before-article-doi"> doi:</span>10.1093/jnci/djt289 </span><span class="cit-ahead-of-print-date"><span class="cit-sep cit-sep-before-article-ahead-of-print-date">first published online </span>October 9, 2013 </span><span class="cit-page-count"><span class="cit-sep cit-sep-before-article-page-count">(</span>2<span class="cit-sep cit-sep-after-article-page-count"> pages)</span> </span></cite>  
                     </div>
                     <div class="cit-extra"><span class="accesscheck jnci;105/21/1594 pdf_extract,full,reprint"></span> 
                        <ul class="cit-views">
                           <li class="first-item"><a href="/content/105/21/1594.extract" rel="extract">Extract</a></li>
                           <li><a href="/content/105/21/1594.full" rel="full-text">Full Text (HTML)</a></li>
                           <li class="last-item"><a href="/content/105/21/1594.full.pdf+html" rel="full-text.pdf">Full Text (PDF)</a></li>
                        </ul>  
                     </div> 
                  </div>
               </ul>
            </div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/105/21/1656.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/105/21/NP.1.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/105/21.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (2013) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    105
                                    </span><span class="slug-issue">
                                    (21):
                                    </span><span class="slug-pages">
                                    1667-1670.
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/djt269" class="slug-doi">10.1093/jnci/djt269</span>
                                    </span>
                                 </cite>
                              
                              
                              <span class="slug-metadata-note ahead-of-print">
                                 
                                 First published online
                                 
                                 <span class="slug-ahead-of-print-date">October 9, 2013</span>
                                 </span>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/105/21/1667.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/105/21/1667.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                        <li><a href="/content/105/21/1667/suppl/DC1" rel="supplemental-data"
                              class="dslink-supplementary-data">Supplementary Data</a></li>
                        <li class="cb-versions">
                           <div><span id="pap-all-versions-label">All Versions of this Article:</span><ol class="version-list">
                                 <li><a href="/content/early/2013/10/04/jnci.djt269">djt269v1</a></li>
                                 <li class="current-li"><span>105/21/1667</span> <span class="current-version">most recent</span></li>
                              </ol>
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=Brief+Communication&amp;sortspec=date&amp;submit=Submit">Brief Communication</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;105/21/1667" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B105%2F21%2F1667&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/105/21/1667.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=105/21/1667&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/105/21/1667.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3Bdjt269&amp;citation=Paoletti%20et%20al.%20105%20%2821%29:%201667&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B105%2F21%2F1667&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=24108811&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B105%2F21%2F1667">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B105%2F21%2F1667">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Progression-Free%20Survival%20as%20a%20Surrogate%20for%20Overall%20Survival%20in%20Advanced%2FRecurrent%20Gastric%20Cancer%20Trials%3A%20A%20Meta-Analysis%3A%20&amp;publicationDate=11%2F06%2F2013&amp;author=Xavier%20Paoletti%2C%20Koji%20Oba%2C%20Yung-Jue%20Bang%2C%20Harry%20Bleiberg%2C%20Narikazu%20Boku%2C%20Olivier%20Bouch%C3%A9%2C%20Paul%20Catalano%2C%20Nozomu%20Fuse%2C%20Stefan%20Michiels%2C%20Markus%20Moehler%2C%20Satoshi%20Morita%2C%20Yasuo%20Ohashi%2C%20Atsushi%20Ohtsu%2C%20Arnaud%20Roth%2C%20Philippe%20Rougier%2C%20Junichi%20Sakamoto%2C%20Daniel%20Sargent%2C%20Mitsuru%20Sasako%2C%20Kohei%20Shitara%2C%20Peter%20Thuss-Patience%2C%20Eric%20Van%20Cutsem%2C%20Tomasz%20Burzykowski%2C%20Marc%20Buyse&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2Fdjt269&amp;volumeNum=105&amp;issueNum=21&amp;startPage=1667&amp;endPage=1670&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/105/21/1667.full?cited-by=yes&amp;legid=jnci;105/21/1667#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/105/21/1667" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/105/21/1667?access_num=/jnci/105/21/1667"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F105%2F21%2F1667&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/105/21/1667.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3APaoletti%20author%3AX.%22"
                              class="cb-art-gs-auth author-link">Articles by  Paoletti, X.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ABuyse%20author%3AM.%22"
                              class="cb-art-gs-auth author-link">Articles by  Buyse, M.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/105/21/1667.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=24108811&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Paoletti%20X&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Paoletti, X.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Oba%20K&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Oba, K.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Bang%20YJ&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Bang, Y. J.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Bleiberg%20H&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Bleiberg, H.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Boku%20N&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Boku, N.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Bouch%C3%A9%20O&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Bouché, O.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Catalano%20P&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Catalano, P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Fuse%20N&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Fuse, N.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Michiels%20S&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Michiels, S.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Moehler%20M&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Moehler, M.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Morita%20S&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Morita, S.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Ohashi%20Y&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Ohashi, Y.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Ohtsu%20A&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Ohtsu, A.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Roth%20A&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Roth, A.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Rougier%20P&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Rougier, P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Sakamoto%20J&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Sakamoto, J.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Sargent%20D&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Sargent, D.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Sasako%20M&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Sasako, M.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Shitara%20K&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Shitara, K.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Thuss-Patience%20P&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Thuss-Patience, P.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Van%20Cutsem%20E&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Van Cutsem, E.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Burzykowski%20T&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Burzykowski, T.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Buyse%20M&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Buyse, M.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="#related">Related articles in this journal</a></li>
                        <li><a href="/content/105/21/1667.full?related-urls=yes&amp;legid=jnci;105/21/1667#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B105%2F21%2F1667&amp;current-view-path=/content/105/21/1667.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/105/21/1667&amp;title=Progression-Free%20Survival%20as%20a%20Surrogate%20for%20Overall%20Survival%20in%20Advanced%2FRecurrent%20Gastric%20Cancer%20Trials%3A%20A%20Meta-Analysis+--+Paoletti%20et%20al.%20105%20%2821%29%3A%201667+--+jnci.j&amp;doi=10.1093/jnci/djt269&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/105/21/1667&amp;title=Progression-Free%20Survival%20as%20a%20Surrogate%20for%20Overall%20Survival%20in%20Advanced%2FRecurrent%20Gastric%20Cancer%20Trials%3A%20A%20Meta-Analysis+--+Paoletti%20et%20al.%20105%20%2821%29%3A%201667+--+jnci.j&amp;doi=10.1093/jnci/djt269&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/105/21/1667&amp;title=Progression-Free%20Survival%20as%20a%20Surrogate%20for%20Overall%20Survival%20in%20Advanced%2FRecurrent%20Gastric%20Cancer%20Trials%3A%20A%20Meta-Analysis+--+Paoletti%20et%20al.%20105%20%2821%29%3A%201667+--+jnci.j&amp;doi=10.1093/jnci/djt269&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/105/21/1667&amp;title=Progression-Free%20Survival%20as%20a%20Surrogate%20for%20Overall%20Survival%20in%20Advanced%2FRecurrent%20Gastric%20Cancer%20Trials%3A%20A%20Meta-Analysis+--+Paoletti%20et%20al.%20105%20%2821%29%3A%201667+--+jnci.j&amp;doi=10.1093/jnci/djt269&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/105/21/1667&amp;title=Progression-Free%20Survival%20as%20a%20Surrogate%20for%20Overall%20Survival%20in%20Advanced%2FRecurrent%20Gastric%20Cancer%20Trials%3A%20A%20Meta-Analysis+--+Paoletti%20et%20al.%20105%20%2821%29%3A%201667+--+jnci.j&amp;doi=10.1093/jnci/djt269&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/105/21/1667&amp;title=Progression-Free%20Survival%20as%20a%20Surrogate%20for%20Overall%20Survival%20in%20Advanced%2FRecurrent%20Gastric%20Cancer%20Trials%3A%20A%20Meta-Analysis+--+Paoletti%20et%20al.%20105%20%2821%29%3A%201667+--+jnci.j&amp;doi=10.1093/jnci/djt269&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-1">Funding</a></li>
                        <li><a href="#notes-1">Notes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/105/21/1667.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/105/21/1667.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>